What Researchers Did
Researchers conducted a retrospective analysis of three patients diagnosed with diquat-induced toxic brain injury who underwent hyperbaric oxygen therapy in the subacute or chronic phase.
What They Found
Post-treatment neuroimaging demonstrated lesion reduction in all patients. At final follow-up, two of the three patients showed improvements in their Neurofunctional Scores and modified Barthel Indices, achieving clinical independence.
What This Means for Canadian Patients
Canadian patients suffering from diquat-induced toxic brain injury might potentially benefit from hyperbaric oxygen therapy to improve neurological outcomes. This treatment could offer a new avenue for recovery in the subacute or chronic phases of this challenging condition.
Canadian Relevance
This study has no direct Canadian connection as indicated by the metadata.
Study Limitations
The primary limitation of this study is its retrospective design and extremely small sample size of only three patients.